SVRA
Savara Inc.NASDAQHealthcare$5.56-0.36%ClosedMarket Cap: $1.14B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.13
P/S
0.00
EV/EBITDA
-9.37
DCF Value
$-0.00
FCF Yield
-8.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-84.0%
ROA
-46.9%
ROIC
-53.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-33.4M | $-32.2M | $-0.13 | — |
| FY 2025 | $0.00 | -Infinity% | $-123.5M | $-118.8M | $-0.53 | — |
| Q3 2025 | $0.00 | NaN% | $-30.3M | $-29.6M | $-0.14 | — |
| Q2 2025 | $0.00 | -Infinity% | $-31.4M | $-30.4M | $-0.14 | — |
| Q1 2025 | $0.00 | -Infinity% | $-28.4M | $-26.6M | $-0.12 | — |
| Q4 2024 | $0.00 | -Infinity% | $-31.2M | $-29.0M | $-0.14 | — |
| FY 2024 | $0.00 | -Infinity% | $-103.2M | $-95.9M | $-0.48 | — |
| Q3 2024 | $0.00 | -Infinity% | $-26.4M | $-24.2M | $-0.11 | — |
| Q2 2024 | $0.00 | -Infinity% | $-23.2M | $-22.2M | $-0.12 | — |
| Q1 2024 | $0.00 | -Infinity% | $-22.5M | $-20.3M | $-0.11 | — |
| Q4 2023 | $0.00 | -Infinity% | $-17.6M | $-16.1M | $-0.09 | — |
| FY 2023 | $0.00 | -Infinity% | $-60.0M | $-54.7M | $-0.33 | — |